Home › NDC Lookup › Ingredients › Magnesium Hydroxide › 00132-0655-01
Pedia-Lax Magnesium hydroxide 400 mg Tablet, Chewable, Bottle of 30 — NDC 00132-0655-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

NDC 00132-0655-01: Pedia-Lax Magnesium hydroxide 400 mg Tablet, Chewable, Bottle of 30

by C.B. Fleet Company, Inc.

This is a package of 30 tablets of Pedia-Lax Magnesium hydroxide 400 mg Tablet, Chewable from C.B. Fleet Company, Inc., first listed with the FDA Mar 2008 and currently FDA-listed; retail pharmacies pay about $0.1523 per tablet (NADAC). It is this product's only package size.

🏷️ FDA NDC (as labeled) 0132-0655-01 billing pads the labeler segment with a zero
OTC FDA-listed Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Nov 19, 2026 · this listing last changed Nov 19, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0132-0655-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0132 labeler · 0655 product · 01 package
Package marketed since
Mar 1, 2008
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
30 EA per package
Barcode (UPC-A, from the NDC)
3 0132065501 8
Medicaid fills, this package
129 prescriptions in the last four reported quarters
FDA record last changed
Nov 19, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0132-0655-01
Product NDC 0132-0655
11-digit billing NDC 00132065501
NCPDP billing unit EA — each (per item)
RxCUI 790436, 1088243
UNII NBZ3QY004S
Application # M007
SPL Set ID 975f24d8-218c-40f4-84a5-558acf34329d
Established class (EPC) Calculi Dissolution Agent; Osmotic Activity
Mechanism of action Magnesium Ion Exchange Activity
Physiologic effect Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption; Inhibition Small Intestine Fluid/Electrolyte Absorption
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status FDA-listed
FDA listing status Listed (active directory)
Marketing start 2008-03-01
Route ORAL
Dosage form TABLET, CHEWABLE
Substance MAGNESIUM HYDROXIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46100010100530
GPI class Pedia-Lax
GCN Seq No 065999
GCN 28165
HICL code 001329
Ingredient (HICL) Magnesium Hydroxide
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name FLEET PEDIA-LAX TABLET CHEW
FDB brand name Pedia-Lax
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 065999
  • GCN: 28165
  • GPI-14 (Medi-Span): 46100010100530
  • HICL (First Databank): 001329
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 790436
Why two NDCs? The FDA registers this code as 0132-0655-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0655-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Magnesium compounds class.

Drug family (ATC) Magnesium compounds, Other urologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FLEET PEDIA-LAX TABLET CHEW Ingredient Magnesium Hydroxide
📖 What it is MedlinePlus · NLM

Magnesium hydroxide is used to treat occasional constipation in children and adults on a short-term basis. Magnesium hydroxide is in a class of medications called saline laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Mostly for occasional constipation. Some Milk of Magnesia suspensions are also used as an antacid for heartburn, sour stomach and acid indigestion. Check your product's label to se...
  • The labels say it generally produces a bowel movement in about ½ to 6 hours. Colace Fast-Acting Saline Laxative lists 30 minutes to 6 hours. That's why many liquids suggest taking...
  • How long does magnesium hydroxide take to work?
  • Shake it well, then measure with the dosing cup that came with it. Drink a full glass (8 oz) of liquid with each dose. It can be taken once a day, preferably at bedtime, or in divi...
📖 Read our full Magnesium Hydroxide guide →
3
Nutrient depletion considerations

Magnesium Hydroxide (OTC drug) may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.152 $4.57 / 30 tablets
Medicaid paysCMS SDUD · 12 mo $0.2193 $6.58 / 30 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Sep 2024 Mar 2025 Oct 2025 Nov 2026 $0.152 $0.151
▲ Up 1% over the last 15 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00132-0655-01 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 30 TABLET, CHEWABLE in 1 BOTTLE 2008-03-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pedia-Lax 400 mgthis 00132-0655-01 C.B. 30 tablets $0.152 — Availability likely —
Walgreens Childrens Saline Laxative 400 mg 00363-9129-30 WALGREEN 30 tablets — — FDA listed —
Childrens Oral Saline Laxative 400 mg 49035-0307-30 WAL-MART 30 tablets — — FDA listed —
CVS Health Childrens Saline Laxative 400 mg 69842-0912-30 CVS 30 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2008
Listed with the FDA since
Mar 2008
📍
2026
Currently FDA-listed
18 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color pink
ShapeRound
ImprintPedia;Lax
Size14 mm
ScoringScored — splits in 2
FlavorWatermelon
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Magnesium Hydroxide inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescolloidal silicon dioxide, FD&C red #40 aluminum lake, flavor, magnesium stearate, maltodextrin, mannitol, sorbitol, stearic acid, sucralose

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerC.B. Fleet Company, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00132
First marketedMar 2008
Product typeHuman Otc Drug
Portfolio23 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 17 words ▾

Uses For relief of occasional constipation This product usually produces abowel movement in 1/2 to 6 hours

⏱️ Dosage and Administration 69 words ▾

Directions Use dosage chart for proper dosing. Doses may be taken as a single daily dose or in divided doses. Drink a full glass (8 ounces) of liquid with each dose. Age Starting dose Starting Dose Maximum dose per day (24 hours) children 6 to under 12 years 3-6 tablets 6 tablets children 2 to under 6 years 1-3 tablets 3 tablets children under 2 years ask a doctor

⚠️ Warnings 1 words ▾

Warnings

🧪 Active Ingredient 9 words ▾

Active Ingredient (in each tablet) Magnesium hydroxide 400 mg

🧪 Inactive Ingredients 19 words ▾

Inactive ingredients colloidal silicon dioxide, FD&C red #40 aluminum lake, flavor, magnesium stearate, maltodextrin, mannitol, sorbitol, stearic acid, sucralose

🎯 Purpose 3 words ▾

Purpose Saline laxative

📄 Ask a Doctor Before Use If 110 words ▾

Ask a doctor before using any laxative if child has kidney disease a magnesium-restricted diet abdominal pain, nausea or vomiting a sudden change in bowel habits lasting more than 2 weeks constipation that continues after 1 week of use, contact your child's doctor already used a laxative for more than 1 week Stop us ing this product and consult a doctor if your child has rectal bleeding does not have a bowel movement within 6 hours of using this product these symptoms maybe signs of a serious condition Keep out of reach of children .

In case of overdose, get medical help or contact Poison Control Center (1-800-222-1222) right away.

📄 Stop Use and Ask a Doctor If 36 words ▾

Stop us ing this product and consult a doctor if your child has rectal bleeding does not have a bowel movement within 6 hours of using this product these symptoms maybe signs of a serious condition

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children . In case of overdose, get medical help or contact Poison Control Center (1-800-222-1222) right away.

📄 Other Information 40 words ▾

Other information each tablet contains : 170 mg of magnesium CHILD RESISTANT CAP The top of the bottle sealed for safety. Do not use if foil imprinted "SEALED for YOUR PROTECTION" is broken of missing. Gluten Free and Sugar Free

📄 Questions or Comments 4 words ▾

Questions? 1-866-255-6960 or www.pedia-lax.com

📄 Package Label / Principal Display Panel 20 words ▾

PRINCIPAL DISPLAY PANEL Pedia-Lax ® Magnesium hydroxide Chewable Laxative 30 chewable tablets Pedia-Lax® Magnesium hydroxide Chewable Laxative 30 chewable tablets

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
129
Units reimbursed last 4 qtrs
13.6K
Gross reimbursed last 4 qtrs
$3K
Avg / prescription
$23.06
Avg / unit
$0.2193
Latest quarter Q1 2026
29Rx
Medicaid pays / ea
$0.2193
gross reimbursed
vs
NADAC / ea
$0.1523
acquisition cost
=
Spread
+$0.0670
+44% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
67% FFS 33% MCO
Fee-for-service · 86 Rx Managed care · 43 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: 2,034 units · 20.3 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 11,530 units · 29.6 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
20.329.6
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 29.6 /100k
2 Michigan 20.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pedia-Lax (this brand).

Top reported reactions

Nausea2,222
Constipation2,218
Pain2,076
Fatigue1,847
Dyspnoea1,717
Fall1,691
Diarrhoea1,549

Age at onset

Neonate19
Infant28
Child39
Adolescent46
Adult1,846
Elderly2,543

Reporter sex

26,237 reports
Male · 42%
Female · 58%
Unknown · 0%

Serious outcomes

Hospitalization12,990
Death3,754
Life-threatening1,772
Disabling1,080
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 2,135 1,287
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.